Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4254652 | 1.00 | HCAR2 (0.47) | HCAR2ATMNPSR1TSHRHPGD | |
| SCHEMBL4254660 | 1.00 | HCAR2 (0.47) | HCAR2ATMNPSR1TSHRHPGD | |
| SCHEMBL29116506 | 0.93 | ATM (0.53) | HCAR2ATMNPSR1TSHRHPGD | |
| SCHEMBL4252748 | 0.89 | ATM (0.57) | HCAR2ATMNPSR1TSHRHPGD | |
| SCHEMBL4252755 | 0.89 | ATM (0.57) | HCAR2ATMNPSR1TSHRHPGD | |
| SCHEMBL6003392 | 0.89 | ATM (0.57) | HCAR2ATMNPSR1TSHRHPGD | |
| SCHEMBL6003124 | 0.87 | HCAR2 (0.51) | HCAR2ATMNPSR1TSHRHPGD | |
| SCHEMBL4253587 | 0.87 | HCAR2 (0.51) | HCAR2ATMNPSR1TSHRHPGD | |
| SCHEMBL4253582 | 0.87 | HCAR2 (0.51) | HCAR2ATMNPSR1TSHRHPGD | |
| SCHEMBL4251446 | 0.85 | HCAR2 (0.53) | HCAR2ATMNPSR1TSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023221562-A1 | CATALYST SOLID COMPONENT FOR OLEFIN POLYMERIZATION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 中国科学院化学研究所 | 2023-11-23 | — | — | WO | claimed |
| WO-2023221562-A1 | CATALYST SOLID COMPONENT FOR OLEFIN POLYMERIZATION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 中国科学院化学研究所 | 2023-11-23 | — | — | WO | disclosed |
| US-20060217565-A1 | Process for producing chromone compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060217565-A1 | Process for producing chromone compound | ENY2, CDY1; CDY1B, CDYL | HCAR2 354/4885ATM 1987/4885NPSR1 937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.